Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 2.942.772.742.942.97

What is the latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS is 2.94 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20252.94
Mar20242.77
Mar20232.74
Mar20222.94
Mar20212.97

How is Sales/Fixed Asset of GLENMARK PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2025 2.94
6.14
Mar2024 2.77
1.09
Mar2023 2.74
-6.80
Mar2022 2.94
-1.01
Mar2021 2.97 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹59,154.8 Cr -4.1% 2.6% 40.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,555.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,889.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,073.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹105,133.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹98,492.9 Cr -3.9% -9.1% -18.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-4.1%

2.6%

40.4%

SENSEX

-2.6%

-10.2%

-1.6%


You may also like the below Video Courses